BrazilMarket Entry & Growth in Brazil
Brazil is Latin America's largest life-sciences market, offering immense opportunity for global brands ready to navigate ANVISA's rigorous framework. Taevas delivers end-to-end regulatory, commercial, and distribution support so you can launch with speed
Four Industries. One Brazil Team.
Select an industry to see regulatory pathways, services, and how Taevas supports your Brazil market entry.
Medical Devices & Equipment
Agencia Nacional de Vigilancia Sanitaria (ANVISA)
Brazil's medical device market exceeds $12 billion and is the largest in Latin America, driven by a vast public health system and growing private sector demand. ANVISA classifies devices into four risk classes (I through IV) and requires product registration via the Cadastro or Registro pathway before any product can be commercially distributed. Taevas provides full regulatory navigation, local authorized representative services, and commercial activation to accelerate your device launch in Brazil.
Regulatory Pathways
ANVISA Cadastro (Class I-II)
Lower-risk devices classified as Class I or II follow the Cadastro pathway, which involves a simplified notification process with ANVISA. Taevas prepares and submits all technical documentation to meet Brazilian standards.
ANVISA Registro (Class III-IV)
Higher-risk devices require a full Registro submission, involving comprehensive clinical, technical, and manufacturing data reviewed by ANVISA. Taevas manages dossier preparation, ANVISA liaison, and timeline tracking throughout.
Import Licence (ANUENCIA)
All imported medical devices must obtain an import licence (Anuencia) from ANVISA prior to each shipment entering Brazil. Taevas coordinates with customs brokers and ANVISA to ensure timely clearance.
Post-Market Surveillance
Registered devices are subject to ongoing vigilance obligations, including adverse event reporting and periodic renewals every ten years. Taevas maintains your compliance calendar and submits vigilance reports on your behalf.
Our Services for Medical Devices in Brazil
Why Global Brands Choose Taevas for Brazil
Taevas combines deep ANVISA regulatory expertise with an established commercial network across Brazil, giving international life-sciences brands a single trusted partner from registration through to revenue.
Deep ANVISA Expertise
Our Brazil regulatory team has hands-on experience across all ANVISA submission pathways for medical devices, pharmaceuticals, cosmetics, and food supplements, reducing approval timelines and minimising costly query cycles.
National Market Reach
Taevas operates across all 26 Brazilian states and the Federal District, with established distributor relationships and logistics infrastructure spanning Sao Paulo, Rio de Janeiro, Belo Horizonte, and beyond.
Accelerated Time to Market
Our pre-built regulatory templates, local Responsavel Tecnico network, and customs clearance partnerships mean your products reach Brazilian shelves faster than competitors navigating the market alone.
Established Distributor Network
We have vetted and active relationships with leading Brazilian medical, pharmaceutical, and consumer health distributors, enabling rapid channel activation without the delays of building partnerships from scratch.
KOL and Clinical Advocacy
Taevas connects international brands with Brazil's most influential healthcare professionals and medical society leaders, building the clinical credibility needed to drive adoption in both public and private health sectors.
Proven Track Record in Latin America
With successful market entries across the region, Taevas brings a proven methodology specifically adapted to Brazil's unique regulatory, cultural, and commercial environment, giving your brand a reliable foundation for long-term growth.
Ready to Enter the Brazil Market?
Speak with a Taevas Brazil specialist today to map your regulatory pathway, identify the right distribution partners, and build a market entry plan designed to generate real revenue.